260 related articles for article (PubMed ID: 10468753)
1. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy.
Ljungberg B; Alamdari FI; Rasmuson T; Roos G
BJU Int; 1999 Sep; 84(4):405-11. PubMed ID: 10468753
[TBL] [Abstract][Full Text] [Related]
2. [An optimal follow-up protocol for renal cell carcinoma based on the occurrence of recurrences after surgery].
Masatoshi M; Masatsugu I; Jun-ichiro I; Shiro B
Nihon Hinyokika Gakkai Zasshi; 2000 Dec; 91(12):700-7. PubMed ID: 11201130
[TBL] [Abstract][Full Text] [Related]
3. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.
Levy DA; Slaton JW; Swanson DA; Dinney CP
J Urol; 1998 Apr; 159(4):1163-7. PubMed ID: 9507823
[TBL] [Abstract][Full Text] [Related]
4. Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival.
Beisland C; Medby PC; Beisland HO
Scand J Urol Nephrol; 2004; 38(4):299-305. PubMed ID: 15669589
[TBL] [Abstract][Full Text] [Related]
5. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
6. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
7. Surgical enucleation for renal cell carcinoma (RCC). Prognostic significance of tumour stage, grade and DNA ploidy.
Di Silverio F; Sciarra A; Flammia GP; Mariani M; De Vico A; Buscarini M
Scand J Urol Nephrol; 1997 Apr; 31(2):123-8. PubMed ID: 9165573
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
9. A generation of laparoscopic nephrectomy: stage-specific surgical and oncologic outcomes for laparoscopic nephrectomy in a single center.
Laird A; Stewart GD; Zhong J; Ang WJ; Cutress ML; Riddick AC; McNeill SA; Tolley DA
J Endourol; 2013 Aug; 27(8):1008-14. PubMed ID: 23634886
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the 1997 tumour, nodes and metastases classification of renal cell carcinoma: experience in 172 patients.
Minervini R; Minervini A; Fontana N; Traversi C; Cristofani R
BJU Int; 2000 Aug; 86(3):199-202. PubMed ID: 10930914
[TBL] [Abstract][Full Text] [Related]
11. Radical nephrectomy for renal cell carcinoma 30 mm. or less: long-term follow results.
Eschwege P; Saussine C; Steichen G; Delepaul B; Drelon L; Jacqmin D
J Urol; 1996 Apr; 155(4):1196-9. PubMed ID: 8632529
[TBL] [Abstract][Full Text] [Related]
12. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
[TBL] [Abstract][Full Text] [Related]
13. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013.
Golijanin B; Pereira J; Mueller-Leonhard C; Golijanin D; Amin A; Mega A; Boorjian SA; Thompson RH; Leibovich BC; Gershman B
Urol Oncol; 2019 Dec; 37(12):932-940. PubMed ID: 31570248
[TBL] [Abstract][Full Text] [Related]
14. Oncological outcome of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma.
Iimura Y; Kihara K; Saito K; Masuda H; Kobayashi T; Kawakami S
Int J Urol; 2008 Jan; 15(1):44-7. PubMed ID: 18184170
[TBL] [Abstract][Full Text] [Related]
15. Metastatic potential of a renal mass according to original tumour size at presentation.
Umbreit EC; Shimko MS; Childs MA; Lohse CM; Cheville JC; Leibovich BC; Blute ML; Thompson RH
BJU Int; 2012 Jan; 109(2):190-4; discussion 194. PubMed ID: 21557795
[TBL] [Abstract][Full Text] [Related]
16. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
17. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.
Jorns JJ; Thiel DD; Lohse C; Williams A; Arnold M; Cheville J; Leibovich B; Parker AS
Urology; 2012 Jul; 80(1):147-50. PubMed ID: 22748870
[TBL] [Abstract][Full Text] [Related]
18. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
Diolombi ML; Cheng L; Argani P; Epstein JI
Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379
[TBL] [Abstract][Full Text] [Related]
19. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]